In agreement with our findings, higher sPD-L1 levels have been determined in colorectal cancer patients relative to controls, and in patients with local lymph node metastasis compared with those without such metastasis [43,44]. The gene discussed is SPDL1; the disease is metastatic malignant neoplasm in the lymph nodes.